| Product Code: ETC6736702 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Artificial Intelligence (AI) in Pharmaceutical Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 China Artificial Intelligence (AI) in Pharmaceutical Market - Industry Life Cycle |
3.4 China Artificial Intelligence (AI) in Pharmaceutical Market - Porter's Five Forces |
3.5 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Artificial Intelligence (AI) in Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare solutions |
4.2.2 Government initiatives and investments in AI technology in pharmaceutical sector |
4.2.3 Rising adoption of AI for drug discovery and development |
4.3 Market Restraints |
4.3.1 Data privacy and security concerns related to patient information |
4.3.2 Lack of skilled professionals in AI and pharmaceutical domain |
4.3.3 Regulatory challenges and uncertainty in the application of AI in pharmaceuticals |
5 China Artificial Intelligence (AI) in Pharmaceutical Market Trends |
6 China Artificial Intelligence (AI) in Pharmaceutical Market, By Types |
6.1 China Artificial Intelligence (AI) in Pharmaceutical Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Machine Learning, 2021- 2031F |
6.1.4 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Other Technologies, 2021- 2031F |
6.2 China Artificial Intelligence (AI) in Pharmaceutical Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Software, 2021- 2031F |
6.2.3 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Services, 2021- 2031F |
6.3 China Artificial Intelligence (AI) in Pharmaceutical Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.3.3 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Clinical Trial, 2021- 2031F |
6.3.4 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Laboratory Automation, 2021- 2031F |
6.3.5 China Artificial Intelligence (AI) in Pharmaceutical Market Revenues & Volume, By Other Applications, 2021- 2031F |
7 China Artificial Intelligence (AI) in Pharmaceutical Market Import-Export Trade Statistics |
7.1 China Artificial Intelligence (AI) in Pharmaceutical Market Export to Major Countries |
7.2 China Artificial Intelligence (AI) in Pharmaceutical Market Imports from Major Countries |
8 China Artificial Intelligence (AI) in Pharmaceutical Market Key Performance Indicators |
8.1 Number of successful AI-driven drug discoveries |
8.2 Percentage increase in AI adoption by pharmaceutical companies |
8.3 Number of collaborations between AI technology firms and pharmaceutical companies |
9 China Artificial Intelligence (AI) in Pharmaceutical Market - Opportunity Assessment |
9.1 China Artificial Intelligence (AI) in Pharmaceutical Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 China Artificial Intelligence (AI) in Pharmaceutical Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 China Artificial Intelligence (AI) in Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Artificial Intelligence (AI) in Pharmaceutical Market - Competitive Landscape |
10.1 China Artificial Intelligence (AI) in Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 China Artificial Intelligence (AI) in Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here